Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 115 filers reported holding Y-MABS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,874,453 | -19.8% | 710,833 | -0.1% | 0.00% | -100.0% |
Q2 2023 | $4,832,198 | +45.6% | 711,664 | +7.4% | 0.00% | – |
Q1 2023 | $3,319,851 | +107687.4% | 662,645 | +5.0% | 0.00% | – |
Q4 2022 | $3,080 | -100.0% | 631,294 | -0.3% | 0.00% | -100.0% |
Q3 2022 | $9,126,000 | -3.7% | 632,895 | +1.1% | 0.00% | 0.0% |
Q2 2022 | $9,473,000 | +36.7% | 626,168 | +7.3% | 0.00% | 0.0% |
Q1 2022 | $6,932,000 | -31.1% | 583,529 | -6.0% | 0.00% | 0.0% |
Q4 2021 | $10,066,000 | -38.9% | 620,977 | +7.6% | 0.00% | -50.0% |
Q3 2021 | $16,470,000 | -11.6% | 577,111 | +4.7% | 0.00% | -33.3% |
Q2 2021 | $18,625,000 | +29.9% | 551,047 | +16.2% | 0.00% | +50.0% |
Q1 2021 | $14,337,000 | -32.8% | 474,118 | +10.0% | 0.00% | -50.0% |
Q4 2020 | $21,332,000 | +38.5% | 430,878 | +7.4% | 0.00% | +33.3% |
Q3 2020 | $15,401,000 | -0.6% | 401,177 | +11.9% | 0.00% | 0.0% |
Q2 2020 | $15,489,000 | +93.1% | 358,563 | +16.7% | 0.00% | +50.0% |
Q1 2020 | $8,021,000 | -52.9% | 307,322 | -43.6% | 0.00% | 0.0% |
Q4 2019 | $17,012,000 | +219.7% | 544,436 | +166.6% | 0.00% | +100.0% |
Q3 2019 | $5,321,000 | +41.0% | 204,202 | +23.8% | 0.00% | 0.0% |
Q2 2019 | $3,773,000 | +60.9% | 164,979 | +84.4% | 0.00% | 0.0% |
Q1 2019 | $2,345,000 | -26.1% | 89,470 | -42.7% | 0.00% | – |
Q4 2018 | $3,174,000 | – | 156,064 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 191,176 | $2,271,000 | 2.63% |
Sofinnova Investments, Inc. | 2,194,278 | $26,068,000 | 1.98% |
MPM BioImpact LLC | 443,702 | $5,271,000 | 1.42% |
Soleus Capital Management, L.P. | 238,982 | $2,839,000 | 0.37% |
Lombard Odier Asset Management (Switzerland) SA | 221,774 | $2,635,000 | 0.21% |
Artal Group S.A. | 400,000 | $4,752,000 | 0.20% |
Polar Capital Holdings Plc | 2,877,671 | $34,187,000 | 0.15% |
ASHFORD CAPITAL MANAGEMENT INC | 106,770 | $1,268,000 | 0.14% |
Cormorant Asset Management, LP | 150,000 | $1,782,000 | 0.14% |
Virtus ETF Advisers LLC | 23,646 | $281,000 | 0.13% |